NASDAQ · Medical - Care Facilities

ASTH (ASTH) Stock

$36.33 -0.51% NASDAQ: ASTH Healthcare

Valuation

MetricValue
Price$36.33
Market Cap$1.80B
P/E Ratio63.95
P/B Ratio2.39
P/S Ratio0.54
EPS (TTM)$0.46
52-Week High$51.55
52-Week Low$18.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE5.66%
ROA3.57%
ROCE14.13%
Gross Margin9.30%
Operating Margin2.47%
Net Margin0.86%
Debt/Equity1.33
Current Ratio1.40

Annual Financials (USD)

Metric20212022202320242025
Revenue$774.0M$1.1B$1.4B$2.0B$3.2B
Operating Profit$98.0M$104.0M$85.0M$89.0M$79.0M
Net Profit$69.0M$45.0M$61.0M$43.0M$22.0M
EPS$1.52$0.99$1.29$0.90$0.46
Op Margin12.7%9.1%6.1%4.4%2.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$867.0M$966.0M$933.0M$1.4B$2.2B
Total Liabilities$357.0M$408.0M$523.0M$841.0M$1.7B
Cash$233.0M$288.0M$294.0M$288.0M$429.0M
Borrowings$201.0M$229.0M$321.0M$472.0M$1.1B

Latest News

Astrana Health (ASTH) Stock Looks Fully Valued Following Its 87% Run Simply Wall St. · Jul 16, 2026 2 Reasons to Like ASTH and 1 to Stay Skeptical StockStory · Jul 15, 2026 ASTH: Raising target price to $51.00 Argus Research · Jul 15, 2026 Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call PR Newswire · Jul 14, 2026 Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth PR Newswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$70.0M$82.0M$68.0M$52.0M$115.0M
Investing Cash Flow$-3.0M$-30.0M$-94.0M$-200.0M$-549.0M
Financing Cash Flow$-7.0M$-5.0M$-15.0M$-14.0M$-28.0M
Net Cash Flow$39.0M$55.0M$6.0M$-5.0M$145.0M
Free Cash Flow$51.0M$59.0M$40.0M$44.0M$104.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA15.90
FCF Yield8.01%
Quick Ratio1.35
Interest Coverage1.58
Return 1Y82.67%
Return 3Y21.67%
Return 5Y-62.83%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHC $30.95 -3.99% 14.92 $2.88B 0.00%
AVAH $9.29 -0.48% 5.98 $2.02B 0.00%
HCSG $23.30 +0.95% 23.69 $1.60B 0.00%
LFST $10.54 +0.57% 390.00 $4.09B 0.00%
MD $26.51 +0.11% 11.87 $2.18B 0.00%

About ASTH

ASTH stock trades at $36.33 with a market capitalization of $1.80B. The stock is valued at a price-to-earnings (P/E) ratio of 63.95, price-to-book of 2.39, price-to-sales of 0.54. Over the past 52 weeks the stock has ranged between $18.08 and $51.55, and currently trades 29.5% below its 52-week high.

On profitability, ASTH generates a return on equity (ROE) of 5.66%, return on capital employed of 14.13%, an operating margin of 2.47%, a net profit margin of 0.86%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides